With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund

Healthcare investment firm LSP has raised what it says is the largest ever European fund focused on life sciences ventures.

The Amsterdam, Netherlands-headquartered firm aimed to bring in $450 million in the final fundraiser for its LSP 6 life science private equity fund but has ended up with $620 million (€550 million) to invest in European firms developing new medications or medical technologies.